Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1

Journal of General Virology

Volumn 84, Issue 3, 2003, Pages 573-580

  Blomqvist, Soile ^a   Bruu, Anne Lise ^b   Stenvik, Mirja ^a   Hovi, Tapani ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHIMERIC PROTEIN; NEUTRALIZING ANTIBODY; NUCLEOTIDE; ORAL POLIOMYELITIS VACCINE; PROTEIN VP1; RNA POLYMERASE; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CASE REPORT; FECES; FINLAND; GENETIC RECOMBINATION; HUMAN; IMMUNIZATION; MALE; NONHUMAN; POLIOMYELITIS VIRUS; POLIOMYELITIS VIRUS 3; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGENY; VIRUS GENOME; VIRUS ISOLATION; VIRUS RECOMBINANT; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BINDING SITES; CAPSID PROTEINS; CARRIER STATE; CHILD, PRESCHOOL; DNA-DIRECTED RNA POLYMERASES; FECES; FEMALE; GENOME, VIRAL; HUMANS; MALE; MICE; MOLECULAR SEQUENCE DATA; NORWAY; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL; RECOMBINATION, GENETIC; VACCINATION; VIRAL NONSTRUCTURAL PROTEINS;

POLIOVIRUS; RNA VIRUSES; STAPHYLOCOCCUS PHAGE 3A;

EID: 0037370394     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.18708-0     Document Type: Article

References (34)

1. Abraham, G. & Colonno, R. J. (1984). Many rhinovirus serotypes share the same cellular receptor. J Virol 51, 340-345.
2. Balanant, J., Guillot, S., Candrea, A., Delpeyroux, F. & Crainic, R. (1991). The natural genomic variability of poliovirus analysed by a restriction fragment length polymorphism assay. Virology 184, 645-654.
3. Blomqvist, S., Skyttä, A., Roivainen, M. & Hovi, T. (1999). Rapid detection of human rhinoviruses in nasopharyngeal aspirates by a microwell reverse transcription-PCR-hybridisation assay. J Clin Microbiol 37, 2813-2816.
4. Caro, V., Guillot, S., Delpeyroux, F. & Crainic, R. (2001). Molecular strategy for 'serotyping' of human enteroviruses. J Gen Virol 82, 79-91.
5. Centers for Disease Control & Prevention (2001a). Circulation of a type 2 vaccine-derived poliovirus - Egypt, 1982-1993. J Am Med Assoc 285, 1148-1149.
6. Centers for Disease Control & Prevention (2001b). Acute flaccid paralysis associated with circulating vaccine-derived poliovirus - Philippines, 2001. Morb Mortal Wkly Rep 50, 874-875.
7. Chumakov, K. M., Norwood, L. P., Parker, M. L., Dragunsky, E. M., Ran, Y. & Levenbook, I. S. (1992). RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence. J Virol 66, 966-970.
8. Cuervo, N. S., Guillot, S., Romanenkova, N., Combiescu, M., Aubert-Combiescu, A., Seghier, M., Caro, V., Crainic, R. & Delpeyroux, F. (2001). Genomic features of intertypic recombinant Sabin poliovirus strains excreted by primary vaccinees. J Virol 75, 5740-5751.
9. Evans, D. M. A., Dunn, G., Minor, P. D., Schild, G. C., Cann, A. J., Stanway, G., Almond, J. W., Currey, K. & Maizel, J. V. (1985). A single nucleotide change in the 5′ non-coding region of the genome of the Sabin type 3 polio vaccine is associated with increased neurovirulence. Nature 314, 548-550.
10. Furione, M., Guillot, S., Otelea, D., Balanant, J., Candrea, A. & Crainic, R. (1993). Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis. Virology 196, 199-208.
11. Cammack, N. J., Phillips, A., Dunn, G., Patel, V. & Minor, P. D. (1989). Intertypic genomic rearrangements of poliovirus strains in vaccinees. Virology 167, 507-514.
12. Georgescu, M. M., Delpeyroux, F., Tardy-Panit, M., Balanant, J., Combiescu, M., Combiescu, A. A., Guillot, S. & Crainic, R. (1994). High diversity of polio vaccine strains isolated from the central nervous system of patients with vaccine-associated paralytic poliomyelitis. J Virol 68, 8089-8101.
13. Georgescu, M. M., Delpeyroux, F. & Crainic, R. (1995). Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus. J Gen Virol 76, 2343-2348.
14. Georgopoulou, A. & Markoulatos, P. (2001). Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes. Eur J Clin Microbiol Infect Dis 20, 792-799.
15. Guillot, S., Caro, V., Cuervo, N., Korotkova, E., Combiescu, M., Persu, A., Aubert-Combiescu, A., Delpeyroux, F. & Crainic, R. (2000). Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol 74, 8434-8443.
16. Huovilainen, A., Kinnunen, L., Ferguson, M. & Hovi, T. (1988). Antigenic variation among 173 strains of type 3 poliovirus isolated in Finland during the 1984 to 1985 outbreak. J Gen Virol 69, 1941-1948.
17. Jarvis, T. C. & Kirkegaard, K. (1992). Poliovirus RNA recombination - mechanistic studies in the absence of selection. EMBO J 11, 3135-3145.
18. Kew, O., Morris-Glasgow, V., Landaverde, M. & 21 other authors (2002). Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296, 356-359.
19. Kilpatrick, D. R., Nottay, B., Yang, C., Yang, S., Mulders, M. N., Holloway, B., Pallansch, M. A. & Kew, O. M. (1996). Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy. J Clin Microbiol 34, 2990-2996.
20. Kinnunen, L., Pöyry, T. & Hovi, T. (1991). Generation of virus genetic lineages during an outbreak of poliomyelitis. J Gen Virol 72, 2483-2489.
21. Lipskaya, G. Y., Muzychenko, A. R., Kutitova, O. K., Maslova, S. V., Equestre, M., Drozdov, S. G., Bercoff, R. P. & Agol, V. I. (1991). Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine-associated polio cases. J Med Virol 35, 290-296.
22. Liu, H. M., Zheng, D. P., Zhang, L. B., Oberste, M. S., Pallansch, M. A. & Kew, O. M. (2000). Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol 74, 11153-11161.
23. Macadam, A. J., Arnold, C., Howlett, J. & 9 other authors (1989). Reversion of the attenuated and temperature-sensitive phenotypes of the sabin type 3 strain of poliovirus in vaccinees. Virology 172, 408-414.
24. Martin, J., Samoilovich E., Dunn, G., Lackenby, A., Feldman, E., Heath, A., Svirchevskaya, E., Cooper, G., Yermalovich, M. & Minor, P. D. (2002). Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis. J Virol 76, 10921-10928.
25. Minor, P. D. & Dunn, G. (1988). The effect of sequences in the 5′ non-coding region on the replication of polioviruses in the human gut. J Gen Virol 69, 1091-1096.
26. Minor, P. D., Ferguson, M., Evans, D. M. A., Almond, J. W. & Icenogle, J. P. (1986). Antigenic structure of polioviruses of serotypes 1, 2 and 3. J Gen Virol 67, 1283-1291.
27. Minor, P. D., Dunn, G., Evans, D. M. A. & 8 other authors (1989). The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3. J Gen Virol 70, 1117-1123.
28. Mulders, M. N., Lipskaya, G. Y., van der Avoort, H. G., Koopmans, M. P., Kew, O. M. & van Loon, A. M. (1995). Molecular epidemiology of wild poliovirus type 1 in Europe, the Middle East, and the Indian subcontinent. J Infect Dis 171, 1399-1405.
29. Mulders, M. N., Reimerink, J. H. J., Stenvik, M., Alaeddinoglu, I., van der Avoort, H. G. A. M., Hovi, T. & Koopmans, M. P. G. (1999). A Sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site 1. J Gen Virol 80, 907-916.
30. Reimerink, J. H. J., van der Avoort, H. G. A. M., van Loon, A. M. & Koopmans, M. P. G. (1999). Genetic basis for immunological aberrations in poliovirus Sabin serotype 3 strains imported in The Netherlands. J Clin Microbiol 37, 2393-2398.
31. Rico-Hesse, R., Pallansch, M. A., Nottay, B. K. & Kew, O. M. (1987). Geographic distribution of wild type poliovirus type 1 genotypes. Virology 160, 311-322.
32. Sabin, A. B. & Boulger, L. R. (1973). History of Sabin attenuated poliovirus oral live vaccine strains. J Biol Stand 1, 115-118.
33. Stanway, G., Cann, A. J., Hauptmann, R., Hughes, P., Clarke, L. D., Mountford, R. C., Minor, P. D., Schildt, G. C. & Almond, J. W. (1983). The nucleotide sequence of poliovirus type 3 Leon 12 alb: comparison with poliovirus type 1. Nucleic Acids Res 11, 5629-5643.
34. WHO (2001). Polio Laboratory Manual. Geneva: World Health Organization.